Why Is Wall Street Betting Big On RKLB Stock?
Here’s the real story behind Rocket Lab’s astronomical one-year run, and it has nothing to do with a single earnings report.
If you held Rocket Lab (RKLB) over the past year, congratulations. You’ve probably stopped checking your brokerage account out of sheer vertigo. The stock’s +265% return vastly outpaced the S&P 500’s respectable +24% gain, leaving its defense-giant peers like LMT (+13.2%) and NOC (+13.4%) sitting on the launchpad.
So, what lit the fuse on this thing? A single quarter of strong results was a factor, with the company posting record revenue topping $200 million in its latest report, up more than 63% from the year before. But the real answer is bigger, and frankly, more interesting. It’s about the future that is rapidly being secured under contract.
- The Two Different Futures Priced Into Madison Air Solutions Stock
- The Two-Sided Risk You Already Own in Eaton Stock
- The Hidden Volatility Warning in Stryker Stock
- The Radical Bet At The Heart Of SpaceX’s $1.75 Trillion IPO
- How Wide Is the Field of Play for Dell Stock?
- The Everything Boom That Has Dell Scrambling for Parts
Image by WikiImages from Pixabay
A Backlog With Its Own Gravity
Over the past twelve months, Wall Street stopped seeing Rocket Lab as a plucky small-launch provider and started seeing it as a critical piece of U.S. space infrastructure. The proof is in the order book. The company’s backlog of contracted future revenue exploded, jumping 108% year-on-year to more than $2 billion. These aren’t just pipeline projections; they represent executed contracts across commercial and national security sectors.
Demand is coming in so fast that, as management noted, they “booked more launches in the first 3 months of 2026 than we did for all of last year.” A huge chunk of this comes from national security. The HASTE program, which provides hypersonic test capabilities for the Pentagon, now accounts for almost 1/3 of the entire launch backlog. When the world’s most sophisticated defense customers are lining up, investors take notice.
Selling the Next Rocket, Sight Unseen
Here’s the wild part. The bet investors are making extends beyond the company’s proven Electron rocket. They’re betting on Neutron, its next-generation, medium-lift vehicle that hasn’t even had its first flight. Rocket Lab is already signing major contracts for it. This is an incredible vote of confidence, securing years of future revenue for a product still in development.
It’s a brilliant strategy that de-risks a massive capital project. But it also writes a check the engineers now have to cash. The entire long-term financial model, the one that promises fatter margins and bigger scale, hinges on getting that new rocket off the ground.
The market has priced in the promise, but can the company now deliver the machine?
Where Does This Fit In Your Portfolio
Chasing single-name moves is its own kind of risk. The Trefis High Quality (HQ) Portfolio takes the other side of that bet: 30 quality names, sized and re-balanced with discipline, and a track record of outpacing the S&P 500, S&P Mid-cap, and Russell 2000.